Promoted Companies
SORT BY:
Actinium Pharmaceuticals, Inc. (ATNM)
| Total paid for Promotions this month: | $0 | ||
| E-mails this Month: | 1 | ||
| Estimated Volume Generated: | $0 | ||
| Research Report on ATNM: | Click to see | ||
| * The information presented is based on information for May , 2016 | |||
New NYSE Alert [ Short Squeeze Potential?] Jun 03, 2015 08:03
Hi,
New Trade Alert: Actinium Pharmaceuticals, Inc. [ NYSE: ATNM ]
Highlights:
Last Close: $3.01 | Yahoo Finance Quote
Key level to watch on present momentum is 4.35.
ATNM has rallied 68% from 2.57 on May 20 to as high as 4.34 on May 26. May 26th (just a few days ago) witnessed upwards of 43% in intraday gains. This showcases massive historical upside opportunity.
ATNM consolidated after its huge
...read more
| Promoter: | AwesomeStocks.com | Paying Party: | SmallCapSpecialist LLC |
| Stocks covered: | Compensation: | Avg $ Volume for Period: |
| ATNM | $30,000 | 4,128,443 |
| Max Profit: 1.29 % | Gain at close: -3.55 % |
Biotech play with near term catalysts' Jun 02, 2015 15:00
View this email in your browser
Good morning everyone, Our own Small-Cap oracle has identified this potentially undervalued biotech play. Actinium Pharmaceuticals Inc. (NYSE-MKT: ATNM) “There are three targeted therapies for attacking cancerous cells in the human body: alpha-emitters, beta-emitters, and toxins. The company competes with one other
...read more
| Promoter: | First Penny Picks | Paying Party: | Edge Media LLC |
| Stocks covered: | Compensation: | Avg $ Volume for Period: |
| ATNM | $60,000 | 1,667,116 |
| Max Profit: 6.25 % | Gain at close: -5.94 % |
Biotech play with near term catalysts' Jun 02, 2015 15:00
View this email in your browser
Good morning everyone, Our own Small-Cap oracle has identified this potentially undervalued biotech play. Actinium Pharmaceuticals Inc. (NYSE-MKT: ATNM) “There are three targeted therapies for attacking cancerous cells in the human body: alpha-emitters, beta-emitters, and toxins. The company competes with one other
...read more
| Promoter: | Stocks Impossible | Paying Party: | Edge Media LLC |
| Stocks covered: | Compensation: | Avg $ Volume for Period: |
| ATNM | $60,000 | 1,667,116 |
| Max Profit: 6.25 % | Gain at close: -5.94 % |
Biotech play with near term catalysts' Jun 02, 2015 15:00
View this email in your browser
Good morning everyone, Our own Small-Cap oracle has identified this potentially undervalued biotech play. Actinium Pharmaceuticals Inc. (NYSE-MKT: ATNM) “There are three targeted therapies for attacking cancerous cells in the human body: alpha-emitters, beta-emitters, and toxins. The company competes with one other
...read more
| Promoter: | Otcbb Journal | Paying Party: | Edge Media LLC |
| Stocks covered: | Compensation: | Avg $ Volume for Period: |
| ATNM | $60,000 | 1,667,116 |
| Max Profit: 6.25 % | Gain at close: -5.94 % |
Biotech play with several near term catalysts' Jun 02, 2015 09:45
View this email in your browser
Good morning everyone, Our own Small-Cap oracle has identified this potentially undervalued biotech play. Actinium Pharmaceuticals Inc. (NYSE-MKT: ATNM) “There are three targeted therapies for attacking cancerous cells in the human body: alpha-emitters, beta-emitters, and toxins. The company competes with one other
...read more
| Promoter: | Street Picks | Paying Party: | Edge Media LLC |
| Stocks covered: | Compensation: | Avg $ Volume for Period: |
| ATNM | $60,000 | 1,667,116 |
| Max Profit: 6.25 % | Gain at close: -5.94 % |
***** ATNM ***** Mar 16, 2015 21:40
(Mailing list information, including unsubscription instructions, is located at the end of this message.)
Actinium Pharmaceuticals, Inc. is a biopharmaceutical company with a proprietary platform that combines the precision targeting of monoclonal antibodies with the killing power of alpha and beta radioisotopes, the former being the most potent cancer killing agents in existence.
Leveraging this platform and its ties with leading
...read more
| Promoter: | Pennybuster.com | Paying Party: | UNKNOWN |
| Stocks covered: | Compensation: | Avg $ Volume for Period: |
| ATNM | No compensation | UNKNOWN |
| Max Profit: 18.77 % | Gain at close: 16.09 % |
ATNM: Actinium Pharmaceuticals Actimab-A Phase I/II Trial Interim... Nov 06, 2014 13:42
Actinium Pharmaceuticals Actimab-A Phase I/II Trial Interim Data Demonstrate Extension of Overall Survival to 9.1 Months in Elderly Secondary Acute Myeloid Leukemia
If you cannot read this email, click here
Actinium Pharmaceuticals Actimab-A Phase I/II Trial Interim Data Demonstrate Extension of Overall Survival to 9.1 Months in Elderly Secondary Acute Myeloid Leukemia
NEW YORK, NY--(Marketwired - November 06, 2014) -
Significant
...read more
| Promoter: | RedChip Companies, Inc. | Paying Party: | UNKNOWN |
| Stocks covered: | Compensation: | Avg $ Volume for Period: |
| ATNM | Unknown compensation | UNKNOWN |
| Max Profit: 2.60 % | Gain at close: Pending |
ATNM Video Interview - MissionIR Jan 28, 2014 08:31
MissionIR Inside Track: Actinium Pharmaceuticals, Inc. (ATNM)
In a 6-minute interview at the 6th Annual LD Micro Conference in Bel Air, CA, Kaushik Dave, Ph.D., President & CEO of Actinium Pharmaceuticals, Inc.provided an overview of the company, recent accomplishments, and its outlook including the potential and key milestones expected for its two lead compounds: Iomab(TM)-B and Actimab-A.
Key Investment Highlights
Breakthrough
...read more
| Promoter: | MissionIR | Paying Party: | No Third Party |
| Stocks covered: | Compensation: | Avg $ Volume for Period: |
| ATNM | $50,000 | UNKNOWN |
| Max Profit: 4.52 % | Gain at close: Pending |
Actinium Pharmaceuticals, Inc. (ATNM) - Tip of the Week Dec 30, 2013 08:31
Actinium Pharmaceuticals, Inc. (ATNM)
Actinium Pharmaceuticals is a biopharmaceutical company with a proprietary platform that combines the precision targeting of monoclonal antibodies with the killing power of alpha and beta radioisotopes, the former being the most potent cancer killing agents in existence.
View The Full Company Profile
ATNM: MIR, an affiliate of DreamTeamGroup, will receive $50,000 from ATNM for 150 days
...read more
| Promoter: | Tip.us | Paying Party: | No Third Party |
| Stocks covered: | Compensation: | Avg $ Volume for Period: |
| ATNM | $50,000 | UNKNOWN |
| Max Profit: 3.70 % | Gain at close: Pending |